These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11850290)
1. Characterization of a new extended-spectrum beta-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey. Perilli M; Segatore B; De Massis MR; Franceschini N; Bianchi C; Rossolini GM; Amicosante G Antimicrob Agents Chemother; 2002 Mar; 46(3):925-8. PubMed ID: 11850290 [TBL] [Abstract][Full Text] [Related]
2. TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy. Perilli M; Segatore B; de Massis MR; Riccio ML; Bianchi C; Zollo A; Rossolini GM; Amicosante G Antimicrob Agents Chemother; 2000 Sep; 44(9):2537-9. PubMed ID: 10952610 [TBL] [Abstract][Full Text] [Related]
3. TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3. Neuwirth C; Madec S; Siebor E; Pechinot A; Duez JM; Pruneaux M; Fouchereau-Peron M; Kazmierczak A; Labia R Antimicrob Agents Chemother; 2001 Dec; 45(12):3591-4. PubMed ID: 11709345 [TBL] [Abstract][Full Text] [Related]
4. New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis. Palzkill T; Thomson KS; Sanders CC; Moland ES; Huang W; Milligan TW Antimicrob Agents Chemother; 1995 May; 39(5):1199-200. PubMed ID: 7625817 [TBL] [Abstract][Full Text] [Related]
5. Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60. Franceschini N; Perilli M; Segatore B; Setacci D; Amicosante G; Mazzariol A; Cornaglia G Antimicrob Agents Chemother; 1998 Jun; 42(6):1459-62. PubMed ID: 9624494 [TBL] [Abstract][Full Text] [Related]
6. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital. Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971 [TBL] [Abstract][Full Text] [Related]
7. [Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins]. Rodríguez C; Radice M; Perazzi B; Castro S; Juárez J; Santini P; Vay C; Famiglietti A; Gutkind G Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):122-6. PubMed ID: 15757582 [TBL] [Abstract][Full Text] [Related]
18. Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 beta-lactamase produced by Proteus mirabilis strains. Bret L; Chanal C; Sirot D; Labia R; Sirot J J Antimicrob Chemother; 1996 Aug; 38(2):183-91. PubMed ID: 8877532 [TBL] [Abstract][Full Text] [Related]
19. Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital. Perilli M; Celenza G; Fiore M; Segatore B; Pellegrini C; Luzzaro F; Rossolini GM; Amicosante G J Antimicrob Chemother; 2007 Oct; 60(4):877-80. PubMed ID: 17673478 [TBL] [Abstract][Full Text] [Related]
20. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia. Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]